Frontiers in Neurology,
Journal Year:
2024,
Volume and Issue:
15
Published: June 17, 2024
Background
Sleep
is
disturbed
in
Rett
syndrome
(RTT),
a
rare
and
progressive
neurodevelopmental
disorder
primarily
affecting
female
patients
(prevalence
7.1/100,000
patients)
linked
to
pathogenic
variations
the
X-linked
methyl-CpG-binding
protein
2
(
MECP2
)
gene.
Autonomic
nervous
system
dysfunction
with
predominance
of
sympathetic
(SNS)
over
parasympathetic
(PSNS)
reported
RTT,
along
exercise
fatigue
increased
sudden
death
risk.
The
aim
present
study
was
test
feasibility
continuous
24
h
non-invasive
home
monitoring
biological
vitals
(biovitals)
by
an
innovative
wearable
sensor
device
pediatric
adolescent/adult
RTT
patients.
Methods
A
total
10
(mean
age
18.3
±
9.4
years,
range
4.7–35.5
years)
typical
were
enrolled.
Clinical
severity
assessed
validated
scales.
Heart
rate
(HR),
respiratory
(RR),
skin
temperature
(SkT)
monitored
YouCare
Wearable
Medical
Device
(Accyourate
Group
SpA,
L’Aquila,
Italy).
average
percentage
maximum
HR
(HRmax%)
calculated.
variability
(HRV)
expressed
consolidated
time-domain
frequency-domain
parameters.
HR/LF
(low
frequency)
ratio,
indicating
SNS
activation
under
dynamic
exercise,
Simultaneous
measurement
indoor
air
quality
variables
performed
patients’
contributions
surrounding
water
vapor
partial
pressure
[P
H2O
(pt)]
carbon
dioxide
CO2
indirectly
estimated.
Results
Of
6,559.79
biovital
recordings,
5051.03
(77%)
valid
for
data
interpretation.
wake
hours
9.0
1.1
14.9
h,
respectively.
HRmax
%
[median:
71.86%
(interquartile
61.03–82%)]
3.75
3.19–5.05)]
elevated,
independent
from
wake–sleep
cycle.
majority
HRV
time-
parameters
significantly
higher
p
≤
0.031).
ratio
associated
phenotype
severity,
disease
progression,
clinical
sleep
disorder,
subclinical
hypoxia,
electroencephalographic
observations
multifocal
epileptic
activity
general
background
slowing.
Conclusion
Our
findings
indicate
24-h
RTT.
Moreover,
first
time,
HRmax%
identified
as
potential
objective
markers
fatigue,
illness
progression.
Bioengineering,
Journal Year:
2024,
Volume and Issue:
11(3), P. 222 - 222
Published: Feb. 26, 2024
Background:
Wearable
devices
represent
a
new
approach
for
monitoring
key
clinical
parameters,
such
as
ECG
signals,
research
and
health
purposes.
These
could
outcompete
medical
in
terms
of
affordability
use
out-clinic
settings,
allowing
remote
monitoring.
The
major
limitation,
especially
when
compared
to
implantable
devices,
is
the
presence
artifacts.
Several
authors
reported
relevant
percentage
recording
time
with
poor/unusable
traces
ECG,
potentially
hampering
these
this
purpose.
For
reason,
it
utmost
importance
develop
simple
inexpensive
system
enabling
user
wearable
have
immediate
feedback
on
quality
acquired
signal,
real-time
correction.
Methods:
A
algorithm
that
can
work
real
verify
signal
(acceptable
unacceptable)
was
validated.
Based
statistical
blindly
tested
by
comparison
tracings
previously
classified
two
expert
cardiologists.
Results:
classifications
7200
10s-signal
samples
20
patients
commercial
monitor
were
compared.
has
an
overall
efficiency
approximately
95%,
sensitivity
94.7%
specificity
95.3%.
Conclusions:
results
demonstrate
even
be
used
classify
coarseness,
allow
intervention
subject
or
technician.
Cureus,
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 11, 2024
Electronic
health
record
(EHR)
systems
have
developed
over
time
in
parallel
with
general
advancements
mainstream
technology.
As
artificially
intelligent
(AI)
rapidly
impact
multiple
societal
sectors,
it
has
become
apparent
that
medicine
is
not
immune
from
the
influences
of
this
powerful
Particularly
appealing
how
AI
may
aid
improving
healthcare
efficiency
note-writing
automation.
This
literature
review
explores
current
state
EHR
technologies
healthcare,
specifically
focusing
on
possibilities
for
addressing
challenges
through
automation
dictation
and
processes
integration.
offers
a
broad
understanding
existing
capabilities
potential
advancements,
emphasizing
innovations
such
as
voice-to-text
dictation,
wearable
devices,
AI-assisted
procedure
note
dictation.
The
primary
objective
to
provide
researchers
valuable
insights,
enabling
them
generate
new
within
landscape.
By
exploring
benefits,
challenges,
future
integration,
encourages
development
innovative
solutions,
goal
enhancing
patient
care
delivery
efficiency.
Frontiers in Neurology,
Journal Year:
2024,
Volume and Issue:
15
Published: June 17, 2024
Background
Sleep
is
disturbed
in
Rett
syndrome
(RTT),
a
rare
and
progressive
neurodevelopmental
disorder
primarily
affecting
female
patients
(prevalence
7.1/100,000
patients)
linked
to
pathogenic
variations
the
X-linked
methyl-CpG-binding
protein
2
(
MECP2
)
gene.
Autonomic
nervous
system
dysfunction
with
predominance
of
sympathetic
(SNS)
over
parasympathetic
(PSNS)
reported
RTT,
along
exercise
fatigue
increased
sudden
death
risk.
The
aim
present
study
was
test
feasibility
continuous
24
h
non-invasive
home
monitoring
biological
vitals
(biovitals)
by
an
innovative
wearable
sensor
device
pediatric
adolescent/adult
RTT
patients.
Methods
A
total
10
(mean
age
18.3
±
9.4
years,
range
4.7–35.5
years)
typical
were
enrolled.
Clinical
severity
assessed
validated
scales.
Heart
rate
(HR),
respiratory
(RR),
skin
temperature
(SkT)
monitored
YouCare
Wearable
Medical
Device
(Accyourate
Group
SpA,
L’Aquila,
Italy).
average
percentage
maximum
HR
(HRmax%)
calculated.
variability
(HRV)
expressed
consolidated
time-domain
frequency-domain
parameters.
HR/LF
(low
frequency)
ratio,
indicating
SNS
activation
under
dynamic
exercise,
Simultaneous
measurement
indoor
air
quality
variables
performed
patients’
contributions
surrounding
water
vapor
partial
pressure
[P
H2O
(pt)]
carbon
dioxide
CO2
indirectly
estimated.
Results
Of
6,559.79
biovital
recordings,
5051.03
(77%)
valid
for
data
interpretation.
wake
hours
9.0
1.1
14.9
h,
respectively.
HRmax
%
[median:
71.86%
(interquartile
61.03–82%)]
3.75
3.19–5.05)]
elevated,
independent
from
wake–sleep
cycle.
majority
HRV
time-
parameters
significantly
higher
p
≤
0.031).
ratio
associated
phenotype
severity,
disease
progression,
clinical
sleep
disorder,
subclinical
hypoxia,
electroencephalographic
observations
multifocal
epileptic
activity
general
background
slowing.
Conclusion
Our
findings
indicate
24-h
RTT.
Moreover,
first
time,
HRmax%
identified
as
potential
objective
markers
fatigue,
illness
progression.